Addex Therapeutics Ltd (ADXN)
SIX
0.0228
+0.00040 (+1.79%)
Closed
Oct 7, 2026
Day's Range
0.02220.0228
52 wk Range
0.01800.0690
Financial Statements - ADXN - Addex Therapeutics Ltd
Revenue
29.97K▼ 92.6%
Net Income
-6.72M▼ 195.4%Net Margin -22448.4%
EBITDA
-6.81M▼ 46.2%
Free Cash Flow
-2.17M▲ 59.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 29.97K | 404.10K | 1.61M | 1.42M | 2.91M | 3.61M |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -2.81M | -2.75M | -10.28M | -20.51M | -15.50M | -12.24M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -4.02M | -2.15M | -317.28K | -264.36K | 211.69K | -581.12K |
| Pre Tax Income | -6.84M | -4.90M | -10.55M | -20.80M | -15.35M | -12.85M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -6.72M | 7.05M | -10.55M | -20.80M | -15.35M | -12.85M |
| EPS Basic | -0.06 | 0.07 | -0.14 | -0.46 | -0.45 | -0.48 |
| EPS Diluted | -0.06 | 0.07 | -0.14 | -0.46 | -0.45 | -0.48 |
| Basic Shares Outstanding | 107.37M | 98.11M | 74.30M | 45.18M | 34.11M | 26.68M |
| Diluted Shares Outstanding | 107.37M | 98.11M | 74.30M | 45.18M | 34.11M | 26.68M |
| Ebit | -6.84M | -4.90M | -10.53M | -20.75M | -15.28M | -12.78M |
| Ebitda | -6.81M | -4.66M | -9.91M | -20.16M | -15.15M | -11.82M |
| Net Income Continuous Operations | -6.72M | 7.05M | -10.55M | -20.80M | -15.35M | -12.85M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
